"the big unanswered question is concerns over safety in pregnancy," she says. cgrp levels are lower than normal in pregnant women who have.
.
![]()
.
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid..
.. a little under 60% of these encounters resulted in hospitalization and of these, about 13% required intensive care...fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and